Figure 1
Figure 1. IgM surface expression and light chain usage in CD21low B cells. (A) Representative FACS plots for the expression of indicated B-cell markers in B cells of CVID patients (n = 10). CD19+IgM+ B cells were gated on CD21low and CD21+ naive B cells, according to CD38 and CD21 expression, and IgM surface expression was analyzed as the mean fluorescence intensity (MFI) in CD21+ and CD21low B-cell subpopulations, respectively. (B) The diagram shows no significant difference in the cell-surface expression of IgM between CD21+ and CD21low B cells in CVID. (C) Representative FACS plots demonstrate the expression of IgM and λ light chain on CD21low and naive B cells of CVID patients (n = 4). (D) The diagram shows a significantly decreased usage of κ-light chains in CD21low B cells of CVID patients compared with naive B cells of the same individuals.

IgM surface expression and light chain usage in CD21low B cells. (A) Representative FACS plots for the expression of indicated B-cell markers in B cells of CVID patients (n = 10). CD19+IgM+ B cells were gated on CD21low and CD21+ naive B cells, according to CD38 and CD21 expression, and IgM surface expression was analyzed as the mean fluorescence intensity (MFI) in CD21+ and CD21low B-cell subpopulations, respectively. (B) The diagram shows no significant difference in the cell-surface expression of IgM between CD21+ and CD21low B cells in CVID. (C) Representative FACS plots demonstrate the expression of IgM and λ light chain on CD21low and naive B cells of CVID patients (n = 4). (D) The diagram shows a significantly decreased usage of κ-light chains in CD21low B cells of CVID patients compared with naive B cells of the same individuals.

Close Modal

or Create an Account

Close Modal
Close Modal